Mutational signatures, tumor mutational burden (TMB), tumor indel burden, and variants in cancer driver genes (BRAF, KRAS, POLE, POLD1 and DNA mismatch repair (MMR) genes) were analyzed for available samples. This evidence concerns the gene KRAS and cancer.